Platelet Aggregation Inhibitor [EPC]

Platelet Aggregation Inhibitor [EPC] was reported 571580 times

These side effects are most commonly reported by patients taking drugs of the Platelet Aggregation Inhibitor [EPC] class:

# Drug class Count
0 FATIGUE 34761
1 NAUSEA 29362
2 DYSPNOEA 29348
3 DIARRHOEA 28776
4 DRUG INEFFECTIVE 27603
5 DIZZINESS 24482
6 HEADACHE 22284
7 OFF LABEL USE 21108
8 ASTHENIA 20260
9 FALL 20217
10 PAIN 20049
11 VOMITING 17468
12 PNEUMONIA 17060
13 DEATH 16000
14 MYOCARDIAL INFARCTION 15650
15 ARTHRALGIA 15326
16 MALAISE 14686
17 PRURITUS 14554
18 COUGH 14073
19 WEIGHT DECREASED 14021
20 GASTROINTESTINAL HAEMORRHAGE 13993
21 PAIN IN EXTREMITY 13793
22 RASH 13266
23 CHEST PAIN 12948
24 ANAEMIA 12501
25 CONSTIPATION 12306
26 HYPOTENSION 12252
27 FLUSHING 11879
28 ACUTE KIDNEY INJURY 11820
29 CEREBROVASCULAR ACCIDENT 11756
30 PYREXIA 11653
31 HYPERTENSION 11414
32 BACK PAIN 11326
33 DECREASED APPETITE 10780
34 INSOMNIA 10559
35 RENAL FAILURE 9740
36 ANXIETY 9597
37 CONDITION AGGRAVATED 9197
38 URINARY TRACT INFECTION 9110
39 ABDOMINAL PAIN 8997
40 MUSCLE SPASMS 8868
41 GAIT DISTURBANCE 8819
42 ABDOMINAL PAIN UPPER 8814
43 PRODUCT USE IN UNAPPROVED INDICATION 8604
44 BLOOD PRESSURE INCREASED 8590
45 MYALGIA 8539
46 DRUG INTERACTION 8522
47 CHRONIC KIDNEY DISEASE 8469
48 ATRIAL FIBRILLATION 8440
49 CARDIAC FAILURE CONGESTIVE 8318
50 FEELING ABNORMAL 8298
51 OEDEMA PERIPHERAL 8243
52 DEPRESSION 8237
53 CONFUSIONAL STATE 8209
54 BLOOD GLUCOSE INCREASED 7888
55 PARAESTHESIA 7638
56 DEHYDRATION 7628
57 WEIGHT INCREASED 7507
58 PERIPHERAL SWELLING 7441
59 HAEMOGLOBIN DECREASED 7364
60 DRUG HYPERSENSITIVITY 7254
61 ABDOMINAL DISCOMFORT 7253
62 SOMNOLENCE 7233
63 PRODUCT DOSE OMISSION ISSUE 6794
64 NASOPHARYNGITIS 6658
65 ERYTHEMA 6626
66 CONTUSION 6582
67 SYNCOPE 6499
68 MUSCULAR WEAKNESS 6478
69 HYPOAESTHESIA 6439
70 TREMOR 6392
71 HAEMORRHAGE 6154
72 CORONARY ARTERY DISEASE 5979
73 EPISTAXIS 5974
74 COVID-19 5829
75 HYPERHIDROSIS 5798
76 LOSS OF CONSCIOUSNESS 5733
77 CHEST DISCOMFORT 5384
78 GASTROOESOPHAGEAL REFLUX DISEASE 5362
79 PALPITATIONS 5335
80 VISION BLURRED 5301
81 NEUROPATHY PERIPHERAL 5253
82 BALANCE DISORDER 5237
83 MEMORY IMPAIRMENT 5199
84 DYSPEPSIA 5158
85 SEPSIS 5078
86 PRODUCT USE ISSUE 5025
87 CARDIAC DISORDER 4904
88 ACUTE MYOCARDIAL INFARCTION 4853
89 CHILLS 4767
90 GENERAL PHYSICAL HEALTH DETERIORATION 4735
91 URTICARIA 4687
92 HYPERSENSITIVITY 4674
93 WHITE BLOOD CELL COUNT DECREASED 4667
94 PLATELET COUNT DECREASED 4651
95 INCORRECT DOSE ADMINISTERED 4645
96 THROMBOCYTOPENIA 4644
97 HEART RATE INCREASED 4642
98 CARDIAC FAILURE 4555
99 ASTHMA 4448
100 JOINT SWELLING 4447
101 SINUSITIS 4440
102 INJECTION SITE PAIN 4383
103 THROMBOSIS 4371
104 ALOPECIA 4370
105 DYSPHAGIA 4315
106 FEELING HOT 4302
107 RENAL IMPAIRMENT 4279
108 BLOOD CREATININE INCREASED 4254
109 RENAL FAILURE ACUTE 4253
110 INFECTION 4242
111 ABDOMINAL DISTENSION 4172
112 RECTAL HAEMORRHAGE 4168
113 PULMONARY EMBOLISM 4108
114 DRUG DOSE OMISSION 4080
115 ARTHRITIS 4043
116 HOT FLUSH 4024
117 INFLUENZA 4022
118 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4007
119 BRONCHITIS 3957
120 BLOOD PRESSURE DECREASED 3841
121 ANGINA PECTORIS 3840
122 TRANSIENT ISCHAEMIC ATTACK 3838
123 CARDIAC ARREST 3829
124 VISUAL IMPAIRMENT 3804
125 NEUTROPENIA 3803
126 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3741
127 DIABETES MELLITUS 3740
128 HAEMATOCHEZIA 3739
129 TACHYCARDIA 3603
130 WHEEZING 3600
131 DYSPNOEA EXERTIONAL 3553
132 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3547
133 CATARACT 3539
134 RESPIRATORY FAILURE 3524
135 DRY MOUTH 3521
136 BRADYCARDIA 3456
137 PLEURAL EFFUSION 3430
138 OROPHARYNGEAL PAIN 3421
139 OEDEMA 3419
140 HAEMATURIA 3395
141 OVERDOSE 3391
142 DEEP VEIN THROMBOSIS 3390
143 RHABDOMYOLYSIS 3380
144 HALLUCINATION 3335
145 TOXICITY TO VARIOUS AGENTS 3333
146 UPPER GASTROINTESTINAL HAEMORRHAGE 3283
147 MOBILITY DECREASED 3251
148 HYPONATRAEMIA 3244
149 CEREBRAL HAEMORRHAGE 3226
150 OXYGEN SATURATION DECREASED 3059
151 RHINORRHOEA 3059
152 BURNING SENSATION 3049
153 PRODUCTIVE COUGH 3037
154 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3016
155 PRODUCT QUALITY ISSUE 3008
156 HOSPITALISATION 2975
157 DYSGEUSIA 2973
158 RHEUMATOID ARTHRITIS 2954
159 PSORIASIS 2952
160 DISEASE PROGRESSION 2942
161 MUSCULOSKELETAL STIFFNESS 2936
162 MIGRAINE 2923
163 DRY SKIN 2917
164 GASTROINTESTINAL DISORDER 2899
165 SWELLING 2899
166 ILLNESS 2897
167 HYPOGLYCAEMIA 2886
168 DRUG INTOLERANCE 2844
169 BLOOD CHOLESTEROL INCREASED 2838
170 DYSPHONIA 2830
171 AMNESIA 2781
172 END STAGE RENAL DISEASE 2754
173 STRESS 2753
174 OSTEOARTHRITIS 2745
175 CELLULITIS 2718
176 HYPERKALAEMIA 2714
177 ALANINE AMINOTRANSFERASE INCREASED 2709
178 PULMONARY OEDEMA 2686
179 NECK PAIN 2672
180 MELAENA 2659
181 FLATULENCE 2653
182 MUSCULOSKELETAL PAIN 2632
183 VERTIGO 2631
184 LETHARGY 2612
185 FLUID RETENTION 2580
186 EYE PAIN 2579
187 INTENTIONAL PRODUCT USE ISSUE 2574
188 INFLUENZA LIKE ILLNESS 2552
189 SEIZURE 2549
190 NASAL CONGESTION 2543
191 HYPOKALAEMIA 2525
192 SWELLING FACE 2486
193 SLEEP DISORDER 2472
194 HAEMATEMESIS 2426
195 CORONARY ARTERY OCCLUSION 2415
196 TINNITUS 2386
197 HEART RATE DECREASED 2373
198 INTENTIONAL PRODUCT MISUSE 2367
199 UNEVALUABLE EVENT 2346
200 COGNITIVE DISORDER 2322
201 ARTHROPATHY 2320
202 HAEMATOMA 2319
203 RENAL INJURY 2314
204 ARRHYTHMIA 2302
205 INJURY 2278
206 HEPATIC ENZYME INCREASED 2272
207 POLLAKIURIA 2271
208 AGITATION 2270
209 HAEMOPTYSIS 2270
210 ADVERSE DRUG REACTION 2260
211 BONE PAIN 2255
212 ASPARTATE AMINOTRANSFERASE INCREASED 2244
213 DYSARTHRIA 2236
214 INJECTION SITE BRUISING 2223
215 HERPES ZOSTER 2222
216 ANGIOEDEMA 2220
217 EMOTIONAL DISTRESS 2200
218 SKIN EXFOLIATION 2196
219 UPPER RESPIRATORY TRACT INFECTION 2181
220 RASH PRURITIC 2168
221 PLASMA CELL MYELOMA 2157
222 INTERNATIONAL NORMALISED RATIO INCREASED 2139
223 BLOOD GLUCOSE DECREASED 2115
224 INJECTION SITE HAEMORRHAGE 2112
225 SPEECH DISORDER 2102
226 RENAL DISORDER 2070
227 DYSURIA 2037
228 STOMATITIS 2036
229 NEPHROLITHIASIS 2024
230 GASTRITIS 2018
231 SKIN DISCOLOURATION 2015
232 PANCYTOPENIA 2014
233 MATERNAL EXPOSURE DURING PREGNANCY 2000
234 GASTRIC ULCER 1996
235 FOETAL EXPOSURE DURING PREGNANCY 1975
236 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1971
237 THERAPY INTERRUPTED 1971
238 WHITE BLOOD CELL COUNT INCREASED 1962
239 TYPE 2 DIABETES MELLITUS 1958
240 NERVOUSNESS 1957
241 HYPERGLYCAEMIA 1937
242 TREATMENT NONCOMPLIANCE 1928
243 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1927
244 PANCREATITIS 1913
245 HYPOXIA 1909
246 BLOOD POTASSIUM DECREASED 1894
247 MEDICATION ERROR 1893
248 OSTEOPOROSIS 1881
249 BLISTER 1867
250 DISORIENTATION 1866
251 CONVULSION 1852
252 FEBRILE NEUTROPENIA 1838
253 SKIN BURNING SENSATION 1838
254 HAEMATOCRIT DECREASED 1833
255 DEPRESSED LEVEL OF CONSCIOUSNESS 1821
256 CYSTITIS 1807
257 THROAT IRRITATION 1799
258 BLOOD CREATINE PHOSPHOKINASE INCREASED 1796
259 ANAPHYLACTIC REACTION 1795
260 MALIGNANT NEOPLASM PROGRESSION 1792
261 ADVERSE EVENT 1780
262 RED BLOOD CELL COUNT DECREASED 1778
263 FAECES DISCOLOURED 1777
264 HEAD INJURY 1771
265 THERAPEUTIC RESPONSE UNEXPECTED 1769
266 ORTHOSTATIC HYPOTENSION 1751
267 CHOLELITHIASIS 1740
268 CARDIO-RESPIRATORY ARREST 1736
269 INJECTION SITE ERYTHEMA 1736
270 LUNG DISORDER 1734
271 INFUSION RELATED REACTION 1721
272 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1719
273 DEPRESSED MOOD 1707
274 SWOLLEN TONGUE 1702
275 DISCOMFORT 1699
276 APHASIA 1688
277 MENTAL STATUS CHANGES 1677
278 DISTURBANCE IN ATTENTION 1668
279 UNDERDOSE 1668
280 HAEMORRHAGE INTRACRANIAL 1653
281 SEPTIC SHOCK 1651
282 BLOOD PRESSURE SYSTOLIC INCREASED 1649
283 URINARY RETENTION 1647
284 SLEEP APNOEA SYNDROME 1639
285 HIP FRACTURE 1635
286 CEREBRAL INFARCTION 1625
287 MITRAL VALVE INCOMPETENCE 1622
288 PRESYNCOPE 1622
289 DIVERTICULITIS 1621
290 HEART RATE IRREGULAR 1603
291 METABOLIC ACIDOSIS 1600
292 RESPIRATORY TRACT INFECTION 1586
293 SUICIDAL IDEATION 1585
294 LACTIC ACIDOSIS 1584
295 BLOOD UREA INCREASED 1578
296 THERAPY CESSATION 1574
297 C-REACTIVE PROTEIN INCREASED 1560
298 GOUT 1554
299 HYPERLIPIDAEMIA 1547
300 HYPOACUSIS 1542
301 URINARY INCONTINENCE 1528
302 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1523
303 NEPHROGENIC ANAEMIA 1522
304 FULL BLOOD COUNT DECREASED 1515
305 PRODUCT DOSE OMISSION 1509
306 LOWER GASTROINTESTINAL HAEMORRHAGE 1507
307 EYE IRRITATION 1505
308 LEUKOPENIA 1505
309 COMA 1504
310 DELIRIUM 1502
311 COLITIS 1501
312 LIVER DISORDER 1501
313 BLOOD PRESSURE FLUCTUATION 1496
314 LIVER FUNCTION TEST ABNORMAL 1495
315 EXPOSURE DURING PREGNANCY 1490
316 LOWER RESPIRATORY TRACT INFECTION 1489
317 MYOCARDIAL ISCHAEMIA 1486
318 NIGHT SWEATS 1486
319 SUBDURAL HAEMATOMA 1474
320 LIP SWELLING 1468
321 DRY EYE 1466
322 LIMB INJURY 1464
323 VENTRICULAR TACHYCARDIA 1461
324 PULMONARY HYPERTENSION 1458
325 LABORATORY TEST ABNORMAL 1450
326 ACUTE RESPIRATORY FAILURE 1449
327 RASH ERYTHEMATOUS 1437
328 HYPOTHYROIDISM 1436
329 PERICARDIAL EFFUSION 1436
330 SKIN ULCER 1434
331 LIMB DISCOMFORT 1412
332 ISCHAEMIC STROKE 1410
333 BLOOD ALKALINE PHOSPHATASE INCREASED 1406
334 DYSSTASIA 1405
335 DEMENTIA 1402
336 BLINDNESS 1399
337 GASTRIC DISORDER 1399
338 SURGERY 1397
339 TUBULOINTERSTITIAL NEPHRITIS 1390
340 INFLAMMATION 1387
341 HEMIPARESIS 1386
342 ANGINA UNSTABLE 1383
343 UNRESPONSIVE TO STIMULI 1380
344 HYPOPHAGIA 1376
345 DYSKINESIA 1370
346 DISEASE RECURRENCE 1362
347 ROAD TRAFFIC ACCIDENT 1353
348 THERAPY NON-RESPONDER 1343
349 STAPHYLOCOCCAL INFECTION 1339
350 RASH MACULAR 1336
351 GASTRIC HAEMORRHAGE 1335
352 COAGULOPATHY 1334
353 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1327
354 ILL-DEFINED DISORDER 1327
355 NO ADVERSE EVENT 1322
356 IMPAIRED HEALING 1314
357 DIPLOPIA 1310
358 OCULAR HYPERAEMIA 1307
359 HYPERSOMNIA 1302
360 RESTLESSNESS 1297
361 DRUG EFFECT DECREASED 1279
362 VISUAL ACUITY REDUCED 1277
363 FEELING COLD 1269
364 BLOOD URINE PRESENT 1266
365 NEUTROPHIL COUNT DECREASED 1266
366 SINUS DISORDER 1266
367 AGEUSIA 1260
368 LOCALISED INFECTION 1254
369 CONTRAINDICATED PRODUCT ADMINISTERED 1251
370 RIB FRACTURE 1250
371 PAIN IN JAW 1248
372 VIRAL INFECTION 1242
373 BLOOD SODIUM DECREASED 1239
374 INTERSTITIAL LUNG DISEASE 1234
375 PALLOR 1234
376 INTENTIONAL OVERDOSE 1226
377 EYE SWELLING 1219
378 IRRITABILITY 1219
379 CHROMATURIA 1208
380 HAEMORRHOIDS 1207
381 FREQUENT BOWEL MOVEMENTS 1206
382 CARDIOMEGALY 1203
383 ECZEMA 1201
384 GAIT INABILITY 1201
385 SEASONAL ALLERGY 1197
386 MULTIPLE SCLEROSIS RELAPSE 1195
387 HIATUS HERNIA 1192
388 MOVEMENT DISORDER 1192
389 THERAPEUTIC RESPONSE DECREASED 1189
390 EJECTION FRACTION DECREASED 1188
391 BLOOD POTASSIUM INCREASED 1185
392 PREMATURE BABY 1180
393 ELECTROCARDIOGRAM QT PROLONGED 1177
394 EYE DISORDER 1173
395 COLITIS ULCERATIVE 1167
396 ERECTILE DYSFUNCTION 1165
397 NIGHTMARE 1163
398 DEAFNESS 1149
399 LACRIMATION INCREASED 1148
400 GLYCOSYLATED HAEMOGLOBIN INCREASED 1142
401 JOINT INJURY 1136
402 DEVICE ISSUE 1132
403 BLOOD CALCIUM DECREASED 1129
404 INTERVERTEBRAL DISC PROTRUSION 1129
405 ARTERIOSCLEROSIS 1127
406 CARDIOVASCULAR DISORDER 1126
407 HAEMORRHAGIC STROKE 1125
408 INTESTINAL OBSTRUCTION 1123
409 PNEUMONIA ASPIRATION 1121
410 ASCITES 1120
411 BLOOD PRESSURE ABNORMAL 1118
412 TOOTH DISORDER 1114
413 ABASIA 1098
414 SKIN LESION 1097
415 PRODUCT SUBSTITUTION ISSUE 1096
416 RESPIRATORY DISTRESS 1091
417 ULCER 1088
418 PANCREATITIS ACUTE 1083
419 CORONARY ARTERY STENOSIS 1082
420 DIABETES MELLITUS INADEQUATE CONTROL 1081
421 INTERNAL HAEMORRHAGE 1080
422 MENTAL DISORDER 1078
423 AGGRESSION 1076
424 JAUNDICE 1076
425 SKIN DISORDER 1076
426 EATING DISORDER 1073
427 BLOOD TRIGLYCERIDES INCREASED 1070
428 LEUKOCYTOSIS 1070
429 NEOPLASM MALIGNANT 1070
430 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1069
431 SUBARACHNOID HAEMORRHAGE 1063
432 ARTERIAL OCCLUSIVE DISEASE 1061
433 LYMPHADENOPATHY 1060
434 CARDIOGENIC SHOCK 1051
435 CARDIOMYOPATHY 1050
436 ORAL PAIN 1046
437 FEMUR FRACTURE 1039
438 HYPOMAGNESAEMIA 1032
439 ANHEDONIA 1030
440 EAR INFECTION 1026
441 HEPATIC STEATOSIS 1026
442 POST PROCEDURAL COMPLICATION 1022
443 CIRCULATORY COLLAPSE 1021
444 NOCTURIA 1017
445 MULTIPLE SCLEROSIS 1015
446 WOUND 1015
447 PRURITUS GENERALISED 1012
448 ECONOMIC PROBLEM 1011
449 TRICUSPID VALVE INCOMPETENCE 1006
450 ACCIDENTAL OVERDOSE 1003
451 HEPATIC FUNCTION ABNORMAL 1000
452 RESPIRATORY DISORDER 999
453 BLOOD BILIRUBIN INCREASED 997
454 VENTRICULAR EXTRASYSTOLES 995
455 LUNG NEOPLASM MALIGNANT 993
456 DEVICE MALFUNCTION 992
457 PROSTATE CANCER 992
458 ARTERIOSCLEROSIS CORONARY ARTERY 986
459 MUSCULOSKELETAL DISCOMFORT 980
460 SEDATION 980
461 ULCER HAEMORRHAGE 979
462 FUNGAL INFECTION 977
463 RENAL FAILURE CHRONIC 975
464 SUICIDE ATTEMPT 974
465 BREAST CANCER 973
466 INCORRECT DRUG ADMINISTRATION DURATION 973
467 DRUG DEPENDENCE 972
468 HALLUCINATION, VISUAL 971
469 MIDDLE INSOMNIA 971
470 PULMONARY FIBROSIS 969
471 SNEEZING 968
472 COMPLETED SUICIDE 967
473 ACUTE CORONARY SYNDROME 965
474 DRUG ADMINISTRATION ERROR 965
475 NEURALGIA 964
476 DRUG-INDUCED LIVER INJURY 960
477 ATELECTASIS 955
478 INJECTION SITE PRURITUS 954
479 CARDIAC MURMUR 951
480 PANIC ATTACK 946
481 COORDINATION ABNORMAL 943
482 ERUCTATION 943
483 HYPOCALCAEMIA 943
484 MACULAR DEGENERATION 942
485 VENTRICULAR FIBRILLATION 942
486 BASAL CELL CARCINOMA 940
487 IRON DEFICIENCY ANAEMIA 939
488 MULTI-ORGAN FAILURE 939
489 SCIATICA 939
490 MUSCULOSKELETAL CHEST PAIN 938
491 BODY HEIGHT DECREASED 937
492 TREATMENT FAILURE 937
493 HAEMORRHAGIC ANAEMIA 931
494 ABNORMAL DREAMS 930
495 POOR QUALITY SLEEP 924
496 DUODENAL ULCER 921
497 THERAPEUTIC PRODUCT EFFECT DECREASED 921
498 RASH GENERALISED 920
499 PLATELET COUNT INCREASED 919
500 CORONARY ARTERIAL STENT INSERTION 917
501 BONE DISORDER 910
502 PNEUMONITIS 910
503 FEAR 908
504 SHOCK 907
505 POST PROCEDURAL HAEMORRHAGE 906
506 JOINT STIFFNESS 904
507 HERNIA 896
508 ALTERED STATE OF CONSCIOUSNESS 895
509 ENCEPHALOPATHY 893
510 GASTRIC ULCER HAEMORRHAGE 893
511 FULL BLOOD COUNT ABNORMAL 892
512 RETCHING 890
513 PARKINSON^S DISEASE 888
514 INJECTION SITE SWELLING 885
515 OBESITY 885
516 OBSTRUCTIVE AIRWAYS DISORDER 884
517 RESTLESS LEGS SYNDROME 878
518 GAMMA-GLUTAMYLTRANSFERASE INCREASED 877
519 GLAUCOMA 877
520 CLOSTRIDIUM DIFFICILE INFECTION 876
521 FIBROMYALGIA 876
522 PSORIATIC ARTHROPATHY 873
523 RESPIRATORY TRACT CONGESTION 868
524 ABNORMAL BEHAVIOUR 866
525 CORONARY ARTERY BYPASS 866
526 HEAD DISCOMFORT 866
527 OSTEOPENIA 863
528 ABDOMINAL PAIN LOWER 862
529 FOOT FRACTURE 861
530 CROHN^S DISEASE 860
531 TASTE DISORDER 860
532 SINUS BRADYCARDIA 855
533 HEPATIC FAILURE 854
534 DIVERTICULUM 852
535 PULMONARY MASS 851
536 PHOTOPHOBIA 850
537 MULTIPLE ORGAN DYSFUNCTION SYNDROME 847
538 INCREASED TENDENCY TO BRUISE 844
539 STENT PLACEMENT 841
540 THROAT TIGHTNESS 841
541 SPINAL OSTEOARTHRITIS 840
542 BACK DISORDER 839
543 HYPERCHOLESTEROLAEMIA 837
544 MUSCLE TWITCHING 836
545 PREMATURE DELIVERY 835
546 SKIN HAEMORRHAGE 835
547 CHOKING 834
548 SPINAL FRACTURE 832
549 SHOCK HAEMORRHAGIC 831
550 COLD SWEAT 830
551 GALLBLADDER DISORDER 830
552 VAGINAL HAEMORRHAGE 822
553 SINUS CONGESTION 821
554 GLOMERULAR FILTRATION RATE DECREASED 819
555 PROCEDURAL PAIN 819
556 EYE PRURITUS 817
557 PERIPHERAL COLDNESS 816
558 HEPATITIS 815
559 OSTEOMYELITIS 815
560 EXPIRED PRODUCT ADMINISTERED 812
561 FEEDING DISORDER 806
562 TOOTHACHE 806
563 HEMIPLEGIA 805
564 ATRIAL FLUTTER 803
565 EYE HAEMORRHAGE 803
566 MULTIPLE INJURIES 803
567 FEELING JITTERY 800
568 CARPAL TUNNEL SYNDROME 797
569 KNEE ARTHROPLASTY 796
570 ACTIVITIES OF DAILY LIVING IMPAIRED 795
571 UPPER LIMB FRACTURE 792
572 DIABETIC KETOACIDOSIS 791
573 HYPERPARATHYROIDISM SECONDARY 791
574 PRESCRIBED UNDERDOSE 791
575 PROSTATIC SPECIFIC ANTIGEN INCREASED 789
576 PULMONARY CONGESTION 785
577 EAR PAIN 783
578 PHARMACEUTICAL PRODUCT COMPLAINT 782
579 ROTATOR CUFF SYNDROME 778
580 SKIN CANCER 777
581 RENAL CYST 771
582 GINGIVAL BLEEDING 769
583 PRODUCT DOSE OMISSION IN ERROR 769
584 BODY TEMPERATURE INCREASED 765
585 INTENTIONAL DOSE OMISSION 760
586 SYSTEMIC LUPUS ERYTHEMATOSUS 760
587 BLOOD IRON DECREASED 759
588 INTERVERTEBRAL DISC DEGENERATION 759
589 ACNE 757
590 MICTURITION URGENCY 757
591 FLUID OVERLOAD 753
592 HYPOKINESIA 753
593 GASTROENTERITIS 752
594 NERVOUS SYSTEM DISORDER 751
595 DRUG EFFECT INCOMPLETE 749
596 ANOREXIA 744
597 PRODUCT PRESCRIBING ERROR 743
598 RENAL TUBULAR NECROSIS 743
599 IRRITABLE BOWEL SYNDROME 742
600 INJECTION SITE MASS 741
601 GASTROENTERITIS VIRAL 735
602 CRYING 734
603 OESOPHAGITIS 733
604 TROPONIN INCREASED 728
605 DIZZINESS POSTURAL 722
606 ELECTROLYTE IMBALANCE 722
607 KIDNEY INFECTION 715
608 MYOPATHY 714
609 ORAL CANDIDIASIS 713
610 CAROTID ARTERY STENOSIS 710
611 ELECTROCARDIOGRAM ABNORMAL 709
612 SUPRAVENTRICULAR TACHYCARDIA 707
613 CREATININE RENAL CLEARANCE DECREASED 705
614 PARAESTHESIA ORAL 705
615 ANGER 704
616 BURSITIS 704
617 BENIGN PROSTATIC HYPERPLASIA 702
618 BLOOD PRESSURE DIASTOLIC DECREASED 701
619 MOUTH ULCERATION 701
620 ECCHYMOSIS 699
621 DRUG WITHDRAWAL SYNDROME 697
622 INFUSION SITE PAIN 697
623 STEVENS-JOHNSON SYNDROME 697
624 INJECTION SITE REACTION 696
625 LIVER INJURY 696
626 MUSCULOSKELETAL DISORDER 696
627 RASH PAPULAR 692
628 UROSEPSIS 691
629 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 689
630 PROTEINURIA 688
631 THYROID DISORDER 685
632 VITAMIN D DEFICIENCY 685
633 HYPERCALCAEMIA 684
634 SINUS TACHYCARDIA 684
635 SKIN LACERATION 673
636 ANKLE FRACTURE 671
637 PERIPHERAL VASCULAR DISORDER 671
638 EXOSTOSIS 670
639 IMPAIRED WORK ABILITY 668
640 BACTERIAL INFECTION 667
641 MENTAL IMPAIRMENT 667
642 AORTIC ANEURYSM 665
643 VASCULITIS 665
644 RESPIRATORY ARREST 664
645 LOWER LIMB FRACTURE 662
646 THROMBOSIS IN DEVICE 662
647 LEFT VENTRICULAR DYSFUNCTION 661
648 PNEUMOTHORAX 660
649 MASS 659
650 BLOOD LACTATE DEHYDROGENASE INCREASED 657
651 GENERALISED OEDEMA 657
652 DELUSION 654
653 EMOTIONAL DISORDER 653
654 EOSINOPHILIA 651
655 HEPATIC CIRRHOSIS 651
656 PHARYNGEAL OEDEMA 650
657 NEPHROPATHY 649
658 BRONCHIECTASIS 647
659 REBOUND ACID HYPERSECRETION 643
660 TACHYPNOEA 643
661 MUSCLE ATROPHY 640
662 MUSCLE TIGHTNESS 640
663 EMPHYSEMA 639
664 BLOOD GLUCOSE ABNORMAL 638
665 FLANK PAIN 638
666 OSTEONECROSIS 632
667 VASCULAR STENT THROMBOSIS 632
668 GASTRITIS EROSIVE 630
669 SECRETION DISCHARGE 629
670 ACCIDENTAL EXPOSURE TO PRODUCT 628
671 EXTRA DOSE ADMINISTERED 626
672 BLINDNESS UNILATERAL 623
673 DRUG ERUPTION 621
674 SCAR 619
675 TENDONITIS 619
676 ATRIOVENTRICULAR BLOCK 618
677 BLOOD MAGNESIUM DECREASED 618
678 IMPAIRED GASTRIC EMPTYING 618
679 DRUG TOXICITY 617
680 SPLENOMEGALY 615
681 GLOSSODYNIA 614
682 RASH MACULO-PAPULAR 613
683 BLOOD COUNT ABNORMAL 612
684 LIVER FUNCTION TEST INCREASED 612
685 PRODUCT ADMINISTRATION ERROR 610
686 DRUG ABUSE 609
687 OCULAR DISCOMFORT 609
688 TOXIC EPIDERMAL NECROLYSIS 608
689 LOCAL SWELLING 607
690 TENDERNESS 607
691 PSYCHOTIC DISORDER 603
692 ISCHAEMIC CARDIOMYOPATHY 602
693 CLOSTRIDIUM DIFFICILE COLITIS 601
694 SENSORY DISTURBANCE 600
695 HYPOVOLAEMIA 598
696 TOOTH INFECTION 595
697 RED BLOOD CELL SEDIMENTATION RATE INCREASED 593
698 GROIN PAIN 591
699 LOW BIRTH WEIGHT BABY 590
700 MUCOSAL INFLAMMATION 590
701 MUSCLE SPASTICITY 590
702 CANDIDA INFECTION 589
703 LYMPHOCYTE COUNT DECREASED 589
704 TRANSAMINASES INCREASED 588
705 BODY TEMPERATURE DECREASED 585
706 MYOSITIS 584
707 LACERATION 583
708 MOTOR DYSFUNCTION 583
709 BONE DENSITY DECREASED 581
710 ANAPHYLACTIC SHOCK 580
711 OSTEONECROSIS OF JAW 579
712 PHARYNGITIS 579
713 DIALYSIS 578
714 GASTROINTESTINAL PAIN 578
715 LEFT VENTRICULAR HYPERTROPHY 577
716 SENSORY LOSS 577
717 RALES 575
718 WITHDRAWAL SYNDROME 575
719 SMALL INTESTINAL OBSTRUCTION 572
720 PAIN OF SKIN 570
721 HIP ARTHROPLASTY 568
722 PETECHIAE 566
723 ATAXIA 564
724 LUNG INFILTRATION 564
725 RHINITIS 564
726 DIABETIC NEUROPATHY 562
727 NEOPLASM PROGRESSION 562
728 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 561
729 INCONTINENCE 560
730 DEVICE DISLOCATION 559
731 BRAIN FOG 557
732 EPILEPSY 557
733 THIRST 557
734 MULTIPLE ALLERGIES 554
735 CYANOSIS 553
736 DIASTOLIC DYSFUNCTION 553
737 MALNUTRITION 552
738 MOOD SWINGS 552
739 PRODUCT AVAILABILITY ISSUE 551
740 CAROTID ARTERY OCCLUSION 550
741 PERITONITIS 548
742 PRESCRIBED OVERDOSE 548
743 JOINT RANGE OF MOTION DECREASED 547
744 PULMONARY ARTERIAL HYPERTENSION 547
745 PERICARDITIS 544
746 SYNOVITIS 544
747 ATRIOVENTRICULAR BLOCK COMPLETE 542
748 COVID-19 PNEUMONIA 542
749 BLOOD TEST ABNORMAL 541
750 THINKING ABNORMAL 541
751 ACUTE RESPIRATORY DISTRESS SYNDROME 540
752 DECREASED ACTIVITY 538
753 THERAPEUTIC RESPONSE SHORTENED 538
754 BLADDER DISORDER 533
755 INTENTIONAL DRUG MISUSE 532
756 LOW DENSITY LIPOPROTEIN INCREASED 532
757 PHOTOSENSITIVITY REACTION 532
758 BLOOD GLUCOSE FLUCTUATION 530
759 SEDATION COMPLICATION 529
760 URINE OUTPUT DECREASED 529
761 AORTIC VALVE INCOMPETENCE 528
762 BUNDLE BRANCH BLOCK LEFT 528
763 DRUG RESISTANCE 528
764 BRONCHOSPASM 524
765 INCREASED APPETITE 524
766 TRANSFUSION 524
767 PULMONARY THROMBOSIS 523
768 INFUSION SITE ERYTHEMA 522
769 MALIGNANT MELANOMA 522
770 TENDON RUPTURE 522
771 BREATH SOUNDS ABNORMAL 520
772 CHOLECYSTITIS 520
773 HEPATOTOXICITY 520
774 PARANOIA 520
775 WOUND INFECTION 519
776 CONJUNCTIVITIS 518
777 DYSLIPIDAEMIA 518
778 NERVE COMPRESSION 516
779 PRODUCT STORAGE ERROR 516
780 WRIST FRACTURE 516
781 HAEMORRHOIDAL HAEMORRHAGE 514
782 DRUG LEVEL INCREASED 513
783 HYPERTENSIVE CRISIS 513
784 SPUTUM DISCOLOURED 513
785 MOOD ALTERED 511
786 ANGIOPATHY 510
787 TOOTH FRACTURE 510
788 DIVERTICULUM INTESTINAL HAEMORRHAGIC 509
789 DERMATITIS 508
790 SKIN IRRITATION 508
791 COLON CANCER 507
792 HYPOAESTHESIA ORAL 506
793 GINGIVAL PAIN 505
794 JOINT DISLOCATION 504
795 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 503
796 GANGRENE 502
797 WEIGHT FLUCTUATION 502
798 CARDIAC FAILURE ACUTE 501
799 ABORTION SPONTANEOUS 498
800 CARDIAC OPERATION 497
801 EXERCISE TOLERANCE DECREASED 497
802 HAIR TEXTURE ABNORMAL 497
803 HAEMODIALYSIS 494
804 MUSCLE STRAIN 493
805 CYST 492
806 BACK INJURY 491
807 HOSPICE CARE 491
808 HAIR COLOUR CHANGES 489
809 BLOOD CALCIUM INCREASED 488
810 DRUG PRESCRIBING ERROR 488
811 RESPIRATORY RATE INCREASED 488
812 DERMATITIS CONTACT 486
813 IMPAIRED QUALITY OF LIFE 486
814 VITAMIN D DECREASED 483
815 AORTIC STENOSIS 482
816 EYE INFECTION 482
817 LUNG INFECTION 480
818 CHOLESTASIS 478
819 ESSENTIAL HYPERTENSION 478
820 CARDIAC VALVE DISEASE 477
821 INSURANCE ISSUE 477
822 PROTHROMBIN TIME PROLONGED 476
823 SPINAL DISORDER 476
824 SKIN FISSURES 472
825 FRACTURE 471
826 HYPERTHYROIDISM 471
827 NERVE INJURY 471
828 DUODENAL ULCER HAEMORRHAGE 469
829 ORAL DISCOMFORT 469
830 DECUBITUS ULCER 467
831 DIVERTICULUM INTESTINAL 467
832 DISSEMINATED INTRAVASCULAR COAGULATION 465
833 EXTRASYSTOLES 465
834 PRODUCT PRESCRIBING ISSUE 465
835 BLADDER CANCER 464
836 ORTHOPNOEA 464
837 ASPIRATION 462
838 MOUTH HAEMORRHAGE 462
839 ORAL HERPES 462
840 NEUTROPHIL COUNT INCREASED 461
841 BLOOD ALBUMIN DECREASED 460
842 MYELODYSPLASTIC SYNDROME 460
843 COLITIS ISCHAEMIC 458
844 ATRIOVENTRICULAR BLOCK FIRST DEGREE 457
845 ABNORMAL LOSS OF WEIGHT 456
846 SPINAL COMPRESSION FRACTURE 456
847 PRODUCT PHYSICAL ISSUE 455
848 TOOTH ABSCESS 453
849 THERAPEUTIC AGENT TOXICITY 452
850 LEFT VENTRICULAR FAILURE 451
851 SQUAMOUS CELL CARCINOMA 450
852 BACTERAEMIA 449
853 DERMATITIS ATOPIC 449
854 FACE OEDEMA 449
855 UPPER-AIRWAY COUGH SYNDROME 449
856 INITIAL INSOMNIA 448
857 NODULE 447
858 RENAL PAIN 444
859 PULMONARY HAEMORRHAGE 443
860 APHONIA 442
861 BUNDLE BRANCH BLOCK RIGHT 442
862 INCORRECT PRODUCT ADMINISTRATION DURATION 442
863 AGRANULOCYTOSIS 440
864 PANCREATIC CARCINOMA 440
865 PARALYSIS 440
866 SPINAL COLUMN STENOSIS 440
867 DEVICE DIFFICULT TO USE 439
868 NEEDLE ISSUE 439
869 ABSCESS 438
870 CEREBRAL ISCHAEMIA 438
871 SEROTONIN SYNDROME 438
872 ANURIA 437
873 DEVICE LEAKAGE 437
874 POLYNEUROPATHY 437
875 BLOOD PRESSURE INADEQUATELY CONTROLLED 436
876 LARGE INTESTINE POLYP 436
877 METASTASES TO LIVER 436
878 FOOT DEFORMITY 435
879 MULTIPLE FRACTURES 435
880 NO THERAPEUTIC RESPONSE 433
881 ANAL INCONTINENCE 432
882 BEDRIDDEN 432
883 DENTAL CARIES 432
884 BRAIN NATRIURETIC PEPTIDE INCREASED 431
885 DEVICE OCCLUSION 431
886 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 430
887 METASTASES TO BONE 429
888 SUDDEN DEATH 428
889 DEVICE RELATED INFECTION 426
890 POLYP 426
891 FACIAL PAIN 425
892 LIGAMENT SPRAIN 425
893 ILEUS 423
894 CARDIAC PACEMAKER INSERTION 422
895 EMBOLISM 422
896 HICCUPS 421
897 MYOCLONUS 421
898 RETROPERITONEAL HAEMORRHAGE 421
899 EAR DISCOMFORT 419
900 IMMUNODEFICIENCY 419
901 APPLICATION SITE ERYTHEMA 416
902 CATHETERISATION CARDIAC 416
903 DRUG EXPOSURE DURING PREGNANCY 415
904 PRODUCT ADMINISTRATION INTERRUPTED 415
905 SQUAMOUS CELL CARCINOMA OF SKIN 414
906 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 413
907 TEMPERATURE INTOLERANCE 412
908 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 411
909 PAROSMIA 411
910 APATHY 410
911 DRY THROAT 410
912 PRODUCT USE COMPLAINT 408
913 PURPURA 408
914 SCAB 408
915 BRAIN OEDEMA 407
916 DIARRHOEA HAEMORRHAGIC 407
917 WALKING AID USER 407
918 POLYURIA 405
919 BONE MARROW FAILURE 404
920 HIGH DENSITY LIPOPROTEIN DECREASED 404
921 ANOSMIA 403
922 INJECTION SITE HAEMATOMA 403
923 IMMUNE SYSTEM DISORDER 402
924 QUALITY OF LIFE DECREASED 402
925 VITAMIN B12 DEFICIENCY 402
926 ACIDOSIS 401
927 DISABILITY 400
928 SENSATION OF FOREIGN BODY 400
929 SPINAL PAIN 400
930 HEPARIN-INDUCED THROMBOCYTOPENIA 398
931 INFUSION SITE SWELLING 398
932 BLOOD URIC ACID INCREASED 397
933 URINARY TRACT DISORDER 397
934 ISCHAEMIA 394
935 PNEUMONIA BACTERIAL 394
936 VITREOUS FLOATERS 394
937 GLUCOSE TOLERANCE IMPAIRED 393
938 INJECTION SITE RASH 393
939 HALLUCINATION, AUDITORY 392
940 PULMONARY ALVEOLAR HAEMORRHAGE 392
941 TOOTH LOSS 392
942 ANEURYSM 391
943 DRUG EFFECT LESS THAN EXPECTED 389
944 HEPATOMEGALY 388
945 SCRATCH 388
946 VENTRICULAR HYPOKINESIA 387
947 CARDIAC FAILURE CHRONIC 386
948 CHRONIC SINUSITIS 386
949 PELVIC FRACTURE 386
950 SLUGGISHNESS 386
951 ADRENAL INSUFFICIENCY 385
952 AFFECT LABILITY 385
953 RETINAL HAEMORRHAGE 384
954 HYPOVOLAEMIC SHOCK 383
955 POSTOPERATIVE WOUND INFECTION 382
956 CHOLECYSTECTOMY 379
957 NON-CARDIAC CHEST PAIN 379
958 ESCHERICHIA INFECTION 378
959 LARYNGITIS 378
960 SARS-COV-2 TEST POSITIVE 378
961 DUODENITIS 377
962 CARDIAC FLUTTER 374
963 INTRAOCULAR PRESSURE INCREASED 374
964 RADICULOPATHY 374
965 RIGHT VENTRICULAR FAILURE 372
966 CARDIAC TAMPONADE 371
967 PSYCHOMOTOR HYPERACTIVITY 370
968 BLOOD PRESSURE SYSTOLIC DECREASED 369
969 BOWEL MOVEMENT IRREGULARITY 369
970 SKIN INFECTION 368
971 VENTRICULAR HYPERTROPHY 368
972 DRUG DOSE OMISSION BY DEVICE 367
973 IMPAIRED DRIVING ABILITY 367
974 PARKINSONISM 367
975 RENAL FUNCTION TEST ABNORMAL 367
976 PRE-EXISTING CONDITION IMPROVED 366
977 ACUTE HEPATIC FAILURE 364
978 EYELID OEDEMA 364
979 FACIAL PARALYSIS 364
980 RHINITIS ALLERGIC 364
981 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 363
982 MADAROSIS 363
983 TARDIVE DYSKINESIA 363
984 ABNORMAL FAECES 362
985 INGUINAL HERNIA 360
986 BLOOD LOSS ANAEMIA 359
987 EXTRAPYRAMIDAL DISORDER 359
988 FOETAL GROWTH RESTRICTION 359
989 STOMACH DISCOMFORT 359
990 INFARCTION 358
991 TOOTH EXTRACTION 358
992 SUPRAVENTRICULAR EXTRASYSTOLES 357
993 HUNGER 356
994 URINE ODOUR ABNORMAL 356
995 INTERNATIONAL NORMALISED RATIO DECREASED 355
996 LYMPHOEDEMA 355
997 MUSCLE DISORDER 355
998 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 354
999 HYDRONEPHROSIS 354